This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
July 17, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that its
TomoTherapy® Systems have received the highest composite overall user satisfaction rating among radiation treatment delivery systems in the U.S., according to the Q2 2014 MD Buyline Market Intelligence Briefing
™. The latest ratings show continuously improving customer satisfaction during the past one-and-a-half years as Accuray demonstrated significant and sustained improvements.
In rating Accuray, MD Buyline* reports higher scores for system performance, system reliability, service response time and applications training for both the CyberKnife and TomoTherapy Systems, validating the company's focus on service excellence and technology performance. TomoTherapy System users believe that the system is a workhorse, with the report indicating that they "love this system and believe that it is one of the best systems on the market for radiation oncology treatments." CyberKnife System users also conveyed positive experiences, stating that they are "pleased with the level of flexibility the system allows" and that it is a "solid and durable system."